DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Ausgabe 03 · Volume 87 · 2002 DOI: 10.1055/s-007-35601

Commentary

  • 362
    Brown, Mark A.:

    Platelets: A New Target for Gene Therapy of Haemophilia B

  • 364
    McEver, Rodger P.:

    P-selectin and PSGL-1: Exploiting Connections Between Inflammation and Venous Thrombosis

    • In Focus

  • 366
    Rodriguez, M. H.; Enjolras, N.; Plantier, J. L.; Réa, M.; Leboeuf, M.; Uzan, G.; Bordet, J. C.; Négrier, C.:

    Expression of Coagulation Factor IX in a Haematopoietic Cell Line

  • 374
    Myers, Daniel; Wrobleski, Shirley; Londy, Frank; Fex, Beverly; Hawley, Angela; Schaub, Robert; Greenfield, Lazar; Wakefield, Thomas:

    New and Effective Treatment of Experimentally Induced Venous Thrombosis with Anti-inflammatory rPSGL-Ig

    • Review Article

  • 383
    Dunn, Amy L.; Busch, Michael T.; Wyly, J. Bradley; Abshire, Thomas C.:

    Radionuclide Synovectomy for Hemophilic Arthropathy: A Comprehensive Review of Safety and Efficacy and Recommendation for a Standardized Treatment Protocol

  • 394
    Moser, Tammy L.; Stack, M. Sharon; Wahl, Miriam L.; Pizzo, Salvatore V.:

    The Mechanism of Action of Angiostatin: Can You Teach an Old Dog New Tricks?

  • 402
    Iversen, L. H.; Thorlacius-Ussing, O.:

    Relationship of Coagulation Test Abnormalities to Tumour Burden and Postoperative DVT in Resected Colorectal Cancer

  • 409
    Mills, Joseph D.; Mansfield, Michael W.; Grant, Peter J.:

    Factor XIII – Circulating Levels and the Val34Leu Polymorphism in the Healthy Male Relatives of Patients with Severe Coronary Artery Disease

  • 415
    Miller, G. J.; Bauer, K. A.; Howarth, D. J.; Mitchell, J. P.; Cooper, J. A.:

    Does Inflammatory Proteolytic Activity Contribute to the Increased Factor IX Activation Peptide in Men at High Risk of Coronary Heart Disease? A Preliminary Study

  • 421
    Baker, Ian A.; Pickering, Janet; Elwood, Peter C.; Bayer, Antony; Ebrahim, Shah:

    Fibrinogen, Viscosity and White Blood Cell Count Predict Myocardial, but not Cerebral Infarction: Evidence from the Caerphilly and Speedwell Cohort

  • 426
    Jones, D. W.; Nicholls, P. J.; Donohoe, S.; Gallimore, M. J.; Winter, M.:

    Antibodies to Factor XII Are Distinct from Antibodies to Prothrombin in Patients with the Anti-phospholipid Syndrome

  • 431
    Poon, Man-Chiu; Lillicrap, David; Hensman, Caroline; Card, Robert; Scully, Mary-Frances; Members of Asso cia tion of Hemophilia Clinic Directors of Canada* and Canadian Association of Nurses in Hemophilia Care*:

    Recombinant Factor IX Recovery and Inhibitor Safety: A Canadian Post-licensure Surveillance Study

  • 436
    Shima, Midori; Matsumoto, Tomoko; Fukuda, Kazuyoshi; Kubota, Youko; Tanaka, Ichiro; Nishiya, Katumi; Giles, Alan R.; Yoshioka, Akira:

    The Utility of activated Partial Thromboplastin Time (aPTT) Clot Waveform Analysis in the Investigation of Hemophilia A Patients with very Low Levels of Factor VIII Activity (FVIII:C)

  • 442
    Barrowcliffe, T.W.; Fábregas, P.; Jardi, M.; Cancelas, J.; Rabaneda, M.; Felez, J.:

    Procoagulant Activity of T Lymphoblastoid Cells due to Exposure of Negatively Charged Phospholipid

  • 450
    Yang, Jihong; Lee, Geoffrey F.; Riederer, Markus A.; Kelley, Robert F.:

    Enhancing the Anticoagulant Potency of Soluble Tissue Factor Mutants by Increasing their Affinity to Factor VIIa

  • 459
    Nogami, Keiji; Shima, Midori; Nishiya, Katsumi; Sakurai, Yoshihiko; Tanaka, Ichiro; Giddings, John C.; Saenko, Evgueni L.; Yoshioka, Akira:

    Human Factor VIII Inhibitor Alloantibodies with a C2 Epitope Inhibit Factor Xa-catalyzed Factor VIII Activation: A new Anti-factor VIII Inhibitory Mechanism

  • 466
    Favaloro, Emmanuel J.; Bukuya, Melinda; Martinelli, Teresa; Tzouroutis, Joanne; Duncan, Elizabeth; Welldon, Katie; Collecutt, Margaret; Aumann, Heather; Thom, Jim; Gilmore, Grace:

    A Comparative Multi-laboratory Assessment of Three Factor VIII/von Willebrand Factor Concentrates

  • 477
    Miller, G. J.; Cooke, C. J.; Nanjee, M. N.; Howarth, D. J.; Cooper, J. A.; Stepanova, I. P.; Morrissey, J. H.; Miller, N. E.:

    Factor VII Activation, Apolipoprotein A-I and Reverse Cholesterol Transport: Possible Relevance for Postprandial Lipaemia

  • 483
    Curvers, Joyce; Christella, M.; Thomassen, G. D. L.; de Ronde, Hans; Bertina, Rogier M.; Rosendaal, Frits R.; Tans, Guido; Rosing, Jan:

    Effects of (Pre-)analytical Variables on Activated Protein C Resistance Determined Via a Thrombin Generation-based Assay

  • 493
    Zhang, Lu; Seiffert, Dietmar; Fowler, Bruce J.; Jenkins, George R.; Thinnes, Therese C.; Loskutoff, David J.; Parmer, Robert J.; Miles, Lindsey A.:

    Plasminogen Has a Broad Extrahepatic Distribution

  • 502
    Kolev, Krasimir; Gombás, Judit; Váradi, Balázs; Skopá, Judit; Mede, Katalin; Pitlik, Ervin; Nagy, Zoltán; Machovich, Raymund:

    Immunoglobulin G from Patients with Antiphospholipid Syndrome Impairs the Fibrin Dissolution with Plasmin

  • 509
    Canobbio, Ilaria; Lova, Paolo; Sinigaglia, Fabiola; Balduini, Cesare; Torti, Mauro:

    Proline-rich Tyrosine Kinase 2 and Focal Adhesion Kinase Are Involved in Different Phases of Platelet Activation by vWF

  • 518
    Espinola, Ricardo G.; Pierangeli, Silvia S.; Ghara, Azzudin E.; Harris, E. Nigel:

    Hydroxychloroquine Reverses Platelet Activation Induced by Human IgG Antiphospholipid Antibodies

  • 523
    Xie, Shaoping; O’Regan, David J.; Kakkar, Vijay V.; Scully, Michael F.:

    15 Deoxy Δ12,14 PGJ2 Induces Procoagulant Activity in Cultured Human Endothelial Cells

  • 530
    Lijnen, H. R.; Van Hoef, B.; Frederix, L.; Rio, M.-C.; Collen, D.:

    Adipocyte Hypertrophy in Stromelysin-3 Deficient Mice with Nutritionally Induced Obesity

    • Letters to the Editor

  • 536
    Gris, Jean-Christophe; Balducchi, Jean-Pierre; Quéré, Isabelle; Hoffet, Méderic; Marès, Pierre:

    Enoxaparin Sodium Improves Pregnancy Outcome in Aspirin-resistant Antiphospholipid/Antiprotein Antibody Syndromes

  • 538
    Borja, Javier; Olivella, Pere:

    Enoxaparin and Unfractionated Heparin in Acute Coronary Syndromes without ST-segment Elevation

  • 539
    Anfossi, Giovanni; Russo, Isabella; Massucco, Paola; Mattiello, Luigi; Trovati, Mariella:

    Catecholamines, via β-adrenoceptors, Increase Intracellular Concentrations of 3’,5’-cyclic Guanosine Monophosphate (cGMP) through Nitric Oxide in Human Platelets

  • 540
    Zawadzki, Christophe; Preudhomme, Claude; Gavériaux, Valérie; Amouyel, Philippe; Jude, Brigitte:

    The Arg200Trp Mutation in the Human Tissue Factor Gene

  • 541
    Srivastava, Alok; Mathews, Vikram; Bhurani, Dinesh; Baidya, Shoma; Chandy, Mammen:

    Successful Surgical Hemostasis in Patients with von Willebrand Disease following Infusion of Koate®DVI

  • 543
    Nurden, Alan; Combrié, Robert; Nurden, Paquita:

    Detection of Transfused Platelets in a Patient with Glanzmann Thrombasthenia

  • 544
    Ueshima, Shigeru; Matsuo, Osamu:

    The Differences in Thrombolytic Effects of Administrated Recombinant t-PA between Japanese and Caucasians

  • 547
    Kim, Hyun K.; Song, Kyung S.; Park, Young S.; Kim, Chang M.; Lee, Kyoung R.:

    Method Comparison of Flow Cytometric Assay of Platelet Microparticles and Changes of Platelet Microparticles during Cancer Chemotherapy

  • 548
    Tsai, Han-Mou; Tarr, Phillip I.:

    Rebuttal to: von Willebrand Factor-cleaving Protease in Childhood Diarrhoea-associated Haemolytic Uraemic Syndrome

  • 549
    Lämmle, Bernhard; Hunt, Beverley J.; Haycock, George B.; Furlan, Miha:

    Reply to Rebuttal: von Willebrand Factor-cleaving Protease in Childhood Diarrhoea-associated Haemolytic Uraemic Syndrome

  • 551
    Hemker, H. Coenraad:

    Thrombin Generation in a Reconstituted System: A Comment

  • 552
    Mann, Kenneth G.; Butenas, Saulius:

    Thrombin Generation in a Reconstituted System: A Reply